This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jonghoon Kim: Innovator in Epigenetic Disease Treatment
Introduction
Jonghoon Kim is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of epigenetic disease treatment. His work focuses on developing innovative solutions for serious health conditions.
Latest Patents
Jonghoon Kim holds 1 patent for his invention titled "Compositions and methods for treating epigenetic disease." This patent provides compounds and compositions capable of treating cancer or autoimmune diseases, such as Crohn's disease, along with methods of use.
Career Highlights
Jonghoon Kim is affiliated with the University of California, where he conducts his research and development. His work has garnered attention for its potential impact on treating complex diseases.
Collaborations
Some of his notable coworkers include Dimitrios Iliopoulos and Michael E Jung. Their collaborative efforts contribute to advancing research in the field of epigenetics.
Conclusion
Jonghoon Kim's innovative work in treating epigenetic diseases showcases his commitment to improving health outcomes through scientific research. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile